Common Stock, $0.0001 par value per share
|
492327101
|
(Title of class of securities)
|
(CUSIP number)
|
CUSIP No. 492327101
|
Page 2 of 8
|
1
|
NAMES OF REPORTING PERSONS:
|
|
|
||
Arkin Bio Ventures Limited Partnership
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY:
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS:
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):
☐
|
||||
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER:
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER:
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
|
|
||
☐
|
|
|
|||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
|
|
||
8.69%*
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON:
|
|
|
||
PN
|
|
|
|||
|
|
CUSIP No. 492327101
|
Page 3 of 8
|
1
|
NAMES OF REPORTING PERSONS:
|
|
|
||
Arkin Bio Venture Partners, Ltd.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY:
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS:
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):
☐
|
||||
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER:
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER:
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
|
|
||
☐
|
|
|
|||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
|
|
||
8.69%*
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON:
|
|
|
||
CO
|
|
|
|||
|
|
CUSIP No. 492327101
|
Page 4 of 8
|
1
|
NAMES OF REPORTING PERSONS:
|
|
|
||
Moshe Arkin
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY:
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS:
|
|
|
||
OO
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):
☐
|
||||
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER:
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER:
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
|
|
||
☐
|
|
|
|||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
|
|
||
8.69%*
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON:
|
|
|
||
IN
|
|
|
|||
|
|
CUSIP No. 492327101
|
Page 5 of 8
|
1
|
NAMES OF REPORTING PERSONS:
|
|
|
||
Alon Lazarus
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY:
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS:
|
|
|
||
PF and OO
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):
☐
|
||||
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER:
|
|
|
|
23,038
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER:
|
|
|
||
23,038
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER:
|
|
|
||
2,013,102
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
|
|
||
2,036,140
|
|
|
|||
|
|
||||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
|
|
||
☐
|
|
|
|||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
|
|
||
8.79%*
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON:
|
|
|
||
IN
|
|
|
|||
|
|
|
Page 6 of 8
|
|
Page 7 of 8
|
Item 6. |
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
1 |
Joint Filing Agreement by and among the Reporting Persons, dated as of April 20, 2020 (incorporated by reference to Exhibit 1 of the Original Schedule 13D).
|
2 |
Amended and Restated Investors’ Rights Agreement by and among the Issuer and certain of its stockholders, dated as of March 2, 2020 (incorporated herein by reference to Exhibit 4.1 to the registration statement on Form F-1 (file
number 333-237212) filed with the Securities and Exchange Commission on March 16, 2020, by the Issuer.)
|
3 |
Board resolution of Arkin Bio Venture Partners, Ltd., dated April 20, 2020 (incorporated by reference to Exhibit 4 of the Original Schedule 13D).
|
|
Page 8 of 8
|
Arkin Bio Ventures Limited Partnership
By its General Partner, Arkin Bio Venture Partners, Ltd.
|
|
|
/s/ Moshe Arkin
Name: Moshe Arkin
Title: Director
Arkin Bio Venture Partners, Ltd.
|
/s/ Moshe Arkin
Name: Moshe Arkin
Title: Director
|
|
/s/ Moshe Arkin
Moshe Arkin
|
|
/s/ Alon Lazarus
Alon Lazarus
|